nutrients are essential for the development of fetus 7 . Magnesium is the fourth most abundant cation in human body, which is related to the carbohydrate and fat metabolism 8 . Magnesium plays important role in obstetrics with its relationship to both fetal and maternal wellbeing. Magnesium is one of the important minerals which is required for cell multiplication in a growing fetus and is an essential element of life chemistry in keeping a balanced neuromuscular system 9 . The low concentration of magnesium in serum exposes the subject to a risk of pregnancy complications -hypertension, preeclampsia, IUGR (Intra uterine growth retardation), preterm labour, low birth weight baby and SIDS (sudden infant death syndrome) 10 . The reason for reduction of magnesium concentration is not clear. An increase in the renal clearance during pregnancy may contribute to the reduction in serum magnesium concentration in GDM, since the kidney is the main regulator of the body magnesium concentration 11 . Pregnant women tend to have low magnesium level than non pregnant because of increased demand for mother and growing fetus and increase renal excretion of magnesium which is about 25% more than nonpregnant women due to increased GFR in second and third trimester 12 . The magnesium deficiency in pregnancy leads to life threatening complications for mother as well as their babies that can be prevented by timely detection and proper management of magnesium deficiency. Pregnant women generally have lower plasma magnesium levels compared to nonpregnant women. Bardicef et al. found that women with GDM have lower levels of plasma magnesium 13 .
Materials and Methods
This case-control study was carried out from July 2013 to June 2014 in the Department of Biochemistry, Mymensingh Medical College. A total of 172 subjects were selected by purposive sampling technique from the Outpatient Department of Obstetrics and Gynaecology as well as from Department of Endocrinology, Mymensingh Medical College Hospital. Clinically diagnosed GDM (n=86) was in the case group and it was done on the basis of OGTT by WHO criteria 2013. The case group was subgrouped into Gr-Ia (43) and Gr-Ib (43) at second and third trimesters respectively. The normoglycemic pregnant women at second and third trimesters were taken as control group (n=86) and subgrouped as Gr-IIa (n=43) and Gr-IIb (n=43) at second and third trimester respectively. Pregnant women with previous history of diabetes, hypertension, and other endocrine disorders were excluded from this study. The study protocol was approved by the institutional review committee. Data was collected through a preformed data collection sheet (questionnaire). The variables were age, education, occupation, socioeconomic status, residential address, dietary habit, height, weight, family history of diabetes, previous pregnancy history, and previous history of gestational diabetes mellitus. Written informed consent was obtained from all the participants of the study groups prior to their enrollment into this study. Blood samples taken from pregnant women during OGTT were used for this study. Serum glucose was determined by enzymatic method with GOD-PAP, serum magnesium was determined by colorimetric method using the test kit. The results were analysed statistically and values were expressed as mean (±SD). Student's 't' test was done to see the level of significance. p<0.05 was considered significant.
Result
This study showed that the mean (±SD) of age (in years) of cases and controls were 28.6±3.23 and 27.3±3.13 respectively which showed no significant difference (p=0.778). BMI between cases and controls also showed no significant differences. The mean (±SD) of serum magnesium (mg/dl) were 1.162±0.3.7 and 1.666±0.3.4 in Bangladesh J Med Biochem 2016; 9(2) 60 FA Mishu, MA Muttalib, S Naher et al cases and controls respectively which showed that cases have low level of serum magnesium (p<0.001). Significantly decreased mean serum magnesium level was also found in Gr Ia than that of Gr IIa (1.3884±0.255 mg/dl vs 1.665±0.304 mg/dl; p<0.001). Same significant difference was noted between GIb and GIIb (0.9349±0.145 mg/dl vs 1.667±0.308 mg/dl; p<0.001). 
Discussion
In this study, we estimated serum magnesium levels in GDM subjects (cases) and healthy pregnant women (controls). Serum magnesium concentration of the GDM patients was significantly (P<0.001) lower when compared with that of control. Our study findings is supported by the studies of Bardicef et al. 13 , Takaya et al. 12 and Yinsong Wang et al. 14 . They explained that the decrease in serum magnesium might be due to magnesium depletion caused by osmotic diuresis and by indirect hormonal effects. The low serum magnesium levels seen in the diabetic population may be a consequence of insulin resistance and dietary magnesium intake.
Intestinal hypo absorption may also be a factor for the low serum magnesium levels. In contrast Tasdemir et al. 15 found that there is no statistically significant difference in serum magnesium concentrations between healthy pregnant women and pregnant women with GDM.
In conclusion, significant alteration in serum magnesium level was observed in GDM patients. Therefore it might be recommended that estimation of this biochemical parameter in GDM patients should be carried out for earlier detection and management of the complications of GDM due to depletion of serum magnisium.
